Dr. Bramson is an immunologist with greater than 20 years of experience in cancer and microbial immunology. He created HITS in 2008 to support clinical trials of novel cancer immunotherapies that were being developed through various academic consortia. Under Dr. Bramson’s guidance, HITS has been involved in a range of studies, including natural history studies, vaccine studies and studies of immune tolerance.
Robin obtained her B.Sc. from the University of Western Ontario. As a founding member of HITS, Robin has in depth knowledge of its day-to-day functions and operations. Her expertise extends to the immunological assays performed in the facility where she is known for delivering high quality, reproducible data.
Jamie completed his B.Sc. at Queen’s University, where he studied Biology and Mathematics. He is highly experienced in the methodologies and tools used by HITS to predict and extrapolate trends and patterns from biological data.
Dr. Dvorkin-Gheva completed her Ph.D. studies in computational biology at Tel-Aviv University. Her passion for data analysis, combined with analytical expertise and knowledge of multiple research disciplines allow her to design various analytical workflows and find creative solutions to unconventional questions.
Mary Jo is certified MLT with over 25 years of experience in Histology and Immunohistochemistry. Prior to running the John Mayberry Histology facility she worked in a clinical pathology lab. Mary Jo’s vast experience and expertise in histology make her a critical asset to the facility, which is shown through the quality of the data generated.
Mary is a certified Medical Laboratory Technician (MLT) with over 25 years of histology experience. She began her career in the Anatomical Pathology Laboratory and has since moved into research. Her interest in science and expertise in Histology and Immunohistochemistry deliver reliable and proficient data.
Dr. Paré is a Medical Biochemist who completed a Master’s degree in Human Genetics at McGill University. Dr. Pare’s expertise in bioinformatics, high-throughput biology and genetic epidemiology lead him to found the Genetic and Molecular Epidemiology Laboratory (GMEL).
Ms. Ditta received a Master’s of Science in Forensic Science from King’s College London. She joined GMEL in 2010 where she took on the role as a laboratory manager. She oversees the development of the facility and manages a large, multidisciplinary lab with genomics and proteomics capabilities.
